Published in J Asthma on August 01, 2010
Albuterol Overuse: A Marker of Psychological Distress? J Allergy Clin Immunol Pract (2015) 1.39
Asthma prescribing, ethnicity and risk of hospital admission: an analysis of 35,864 linked primary and secondary care records in East London. NPJ Prim Care Respir Med (2016) 0.77
The Danish National Database for Asthma: establishing clinical quality indicators. Eur Clin Respir J (2016) 0.75
Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med (2005) 6.65
Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins. Chest (2007) 4.96
Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. N Engl J Med (2015) 4.16
Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med (2006) 2.78
Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA (2004) 2.20
New Mexican Hispanic smokers have lower odds of chronic obstructive pulmonary disease and less decline in lung function than non-Hispanic whites. Am J Respir Crit Care Med (2011) 2.07
Burden of concomitant asthma and COPD in a Medicaid population. Chest (2008) 1.87
Spirometry and health status worsen with weight gain in obese smokers but improve in normal-weight smokers. Am J Respir Crit Care Med (2014) 1.77
Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Ann Intern Med (2014) 1.52
Potential benefits and problems with computerized prescriber order entry: analysis of a voluntary medication error-reporting database. Am J Health Syst Pharm (2006) 1.29
Selective cyclooxygenase-2 inhibition and cardiovascular effects: an observational study of a Medicaid population. Arch Intern Med (2005) 1.24
Wood smoke exposure and gene promoter methylation are associated with increased risk for COPD in smokers. Am J Respir Crit Care Med (2010) 1.10
An algorithm for the identification of undiagnosed COPD cases using administrative claims data. J Manag Care Pharm (2006) 1.09
Economic assessment of initial maintenance therapy for chronic obstructive pulmonary disease. Am J Manag Care (2008) 1.06
Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims. Int J Chron Obstruct Pulmon Dis (2011) 1.02
Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population. J Manag Care Pharm (2008) 1.01
Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting. Appl Health Econ Health Policy (2014) 0.98
Ratio of controller to total asthma medications: determinants of the measure. Am J Manag Care (2010) 0.96
Adherence to controller therapy for chronic obstructive pulmonary disease: a review. Curr Med Res Opin (2010) 0.96
Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol vs other inhaled maintenance therapies. Curr Med Res Opin (2009) 0.96
Economic burden prior to COPD diagnosis: a matched case-control study in the United States. Respir Med (2008) 0.95
Drug use patterns in severely mentally ill Medicare beneficiaries: impact of discontinuities in drug coverage. Health Serv Res (2008) 0.94
Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen. Clin Ther (2007) 0.93
Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma. Clin Ther (2009) 0.93
Diabetes and drug-associated hyperkalemia: effect of potassium monitoring. J Gen Intern Med (2010) 0.93
The positive predictive value of a hyperkalemia diagnosis in automated health care data. Pharmacoepidemiol Drug Saf (2010) 0.92
Subacute lack of asthma control as a predictor of subsequent acute asthma exacerbation in a managed care population. Am J Manag Care (2010) 0.90
Subacute lack of asthma control and acute asthma exacerbation history as predictors of subsequent acute asthma exacerbations: evidence from managed care data. J Asthma (2010) 0.90
Interpreting clinical trial results of patient-perceived onset of effect in asthma: methods and results of a Delphi panel. Curr Med Res Opin (2009) 0.89
Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin. A propensity score matched analysis. Thromb Haemost (2016) 0.87
Methylated Genes in Sputum Among Older Smokers With Asthma. Chest (2012) 0.87
Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2010) 0.87
Can outpatient pharmacy data identify persons with undiagnosed COPD? Am J Manag Care (2010) 0.87
Comparative effectiveness of budesonide/formoterol and fluticasone/salmeterol for COPD management. J Med Econ (2011) 0.86
Prevalence of Bartonella infection in domestic cats in Denmark. Vet Res (2002) 0.85
Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry). Am J Cardiol (2008) 0.84
Increasingly restrictive definitions of hyperkalemia outcomes in a database study: effect on incidence estimates. Pharmacoepidemiol Drug Saf (2010) 0.84
Quantifying asthma patient preferences for onset of effect of combination inhaled corticosteroids and long-acting beta2-agonist maintenance medications. Allergy Asthma Proc (2009) 0.84
Cost and resource utilization associated with fluconazole as first-line therapy for invasive candidiasis: a retrospective database analysis. Clin Ther (2010) 0.84
Hospital-based inpatient resource utilization associated with autosomal dominant polycystic kidney disease in the US. J Med Econ (2015) 0.84
Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities. Am J Geriatr Pharmacother (2009) 0.82
Increased methylation of lung cancer-associated genes in sputum DNA of former smokers with chronic mucous hypersecretion. Respir Res (2014) 0.82
Economic burden of chronic bronchitis in the United States: a retrospective case-control study. Int J Chron Obstruct Pulmon Dis (2011) 0.82
Latent variable mixture modeling: a flexible statistical approach for identifying and classifying heterogeneity. Nurs Res (2012) 0.81
Cost-effectiveness analysis of stratified versus stepped care strategies for acute treatment of migraine: The Disability in Strategies for Care (DISC) Study. Pharmacoeconomics (2002) 0.81
Assessing disparities in the receipt of inhaled corticosteroid prescriptions for asthma by Hispanic and non-Hispanic white patients. Ann Am Thorac Soc (2015) 0.81
A genome-wide association study of chronic obstructive pulmonary disease in Hispanics. Ann Am Thorac Soc (2015) 0.81
A randomized validation study comparing embedded versus extracted FACT Head and Neck Symptom Index scores. Qual Life Res (2007) 0.80
Introduction of the Tools for Economic Analysis of Patient Management Interventions in Heart Failure Costing Tool: a user-friendly spreadsheet program to estimate costs of providing patient-centered interventions. Circ Cardiovasc Qual Outcomes (2011) 0.80
A Randomized Study of Electronic Diary versus Paper and Pencil Collection of Patient-Reported Outcomes in Patients with Non-Small Cell Lung Cancer. Patient (2008) 0.79
The role of combination inhaled corticosteroid/long-acting beta-agonist therapy in COPD management. Prim Care Respir J (2010) 0.79
Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population. Curr Med Res Opin (2009) 0.79
Features indicative of cervical abnormality. A factor to be reckoned with in clinical headache work and research? Funct Neurol (2004) 0.79
Development of a modified BODE index as a mortality risk measure among older adults with and without chronic obstructive pulmonary disease. Am J Epidemiol (2013) 0.79
Costs and length of stay for patients with and without sickle cell disease after hysterectomy, appendectomy, or knee replacement. Am J Hematol (2010) 0.78
Effect of combination fluticasone propionate and salmeterol or inhaled corticosteroids on asthma-related outcomes in a Medicare-eligible population. Am J Geriatr Pharmacother (2012) 0.78
Cost-effectiveness of aripiprazole once-monthly compared with paliperidone palmitate once-monthly injectable for the treatment of schizophrenia in the United States. J Med Econ (2014) 0.78
Race-differentiated outcomes in multiple special healthcare taxing districts. Am J Prev Med (2010) 0.78
Geographical distribution of surgical capabilities and disparities in the use of high-volume providers: the case of coronary artery bypass graft. Med Care (2009) 0.78
Influence of medication treatment patterns on resource use for patients hospitalized for schizophrenia. Am J Health Syst Pharm (2008) 0.77
Cost-effectiveness of combination fluticasone propionate-salmeterol 250/50 microg versus salmeterol in severe COPD patients. Int J Chron Obstruct Pulmon Dis (2010) 0.77
Better Asthma Management with Advanced Technology: Creation of an Asthma Utilization Rx Analyzer (AURA) Tool. P T (2009) 0.77
Chronic Bronchitis Is Associated With Worse Symptoms and Quality of Life Than Chronic Airflow Obstruction. Chest (2015) 0.77
Development of the asthma treatment satisfaction measure. Curr Med Res Opin (2009) 0.77
Relationship between short-acting β2-adrenergic agonist use and healthcare costs. Am J Manag Care (2011) 0.76
Moderate symptom-based exacerbations as predictors of severe claims-based exacerbations in asthma. J Asthma (2013) 0.76
Can patients with asthma feel inhaler therapy working right away? Two clinical trials testing the effect of timing of assessment on patient perception. J Asthma (2009) 0.76
An economic assessment of quetiapine and haloperidol in patients with schizophrenia only partially responsive to conventional antipsychotics. Clin Ther (2002) 0.76
Enhancement of DNA cancer vaccine efficacy by combination with anti-angiogenesis in regression of established subcutaneous B16 melanoma. Oncol Rep (2009) 0.76
A cross-sectional retrospective analysis of the regionalization of complex surgery. BMC Surg (2014) 0.75
Reply from the authors. Am J Respir Crit Care Med (2014) 0.75
Hospital and emergency department utilization associated with treatment for chronic obstructive pulmonary disease in a managed-care Medicare population. Curr Med Res Opin (2009) 0.75
Effects of skilled nursing facility structure and process factors on medication errors during nursing home admission. Health Care Manage Rev (2014) 0.75
Racial differences in antipsychotic use: Claims database analysis of Medicaid-insured patients with schizophrenia. Ann Clin Psychiatry (2015) 0.75